细胞外线粒体DNA与N-甲酰肽在创伤和危重症中的作用:一项系统综述
该系统综述纳入54项研究,评估细胞外线粒体DNA和N-甲酰肽在创伤和危重症患者全身炎症中的作用及预测价值。研究最多的人群为创伤(19项)和脓毒症(8项)。与健康对照相比,90.5%(38项)的研究报告患者首个时间点线粒体DNA水平显著升高;81.8%(9项)的研究报告发生炎症并发症的患者至少一个时间点线粒体DNA水平显著高于无并发症者。线粒体DNA预测并发症或结局的ROC曲线下面积在84.6%的曲线中≥0.7,92.9%的比值比、校正比值比、风险比和风险比具有统计学显著性。N-甲酰肽的研究较少,仅1项研究显示其水平较健康对照显著升高。
要点
- 在创伤和脓毒症等急性危重症患者中,细胞外线粒体DNA水平在入院早期即显著升高(90.5%的研究报告首个时间点较健康对照升高)。
- 发生炎症并发症的患者,其血浆/血清线粒体DNA水平在至少一个时间点显著高于无并发症患者(81.8%的研究报告此差异)。
- 线粒体DNA预测并发症或结局的ROC曲线下面积在84.6%的曲线中≥0.7,92.9%的效应量(OR、校正OR、RR、HR)具有统计学显著性。
- N-甲酰肽在全身炎症中的作用及临床效用尚需进一步研究确定。
- 作者建议未来研究需标准化细胞外线粒体DNA和N-甲酰肽的检测方法。
适用人群与场景
- 急性病患者,研究最多的人群为创伤(19项研究)和脓毒症(8项研究)。
- 研究纳入测量细胞外线粒体DNA和/或N-甲酰肽的急性病患者。
研究设计与关键结果
- 系统综述纳入54项研究,检索PubMed和Embase(1971-2017年)。
- 在比较患者与健康对照的研究中,38项(90.5%)报告患者首个报告时间点线粒体DNA水平显著升高;1项比较N-甲酰肽的研究也报告患者水平显著升高。
- 9项研究(81.8%)报告发生原发病炎症并发症的患者至少一个时间点血浆/血清线粒体DNA水平显著高于无炎症并发症患者。
- 线粒体DNA预测并发症或结局的ROC曲线下面积在84.6%的曲线中≥0.7。
- 92.9%的比值比、校正比值比、风险比和风险比具有统计学显著性。
证据类型、等级与局限
- 证据类型:系统综述,纳入54项研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 细胞外线粒体DNA水平在多种急性疾病入院早期即升高,且在发生炎症并发症的患者中更高,可能有助于风险预测和临床决策支持系统。
- 作者认为需要进一步研究确定细胞外N-甲酰肽在全身炎症中的作用及其可能的临床效用。
- 作者建议未来研究需标准化细胞外线粒体DNA和N-甲酰肽的检测方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Extracellular mitochondrial DNA and N-formyl peptides released following tissue damage may contribute to systemic inflammation through stimulation of the innate immune system. In this review, we evaluate existing in vivo human data regarding a role for mitochondrial DNA and N-formyl peptides in producing systemic inflammation in trauma and critical illness, investigate the utility of these molecules in risk prediction and clinical decision support, and provide suggestions for standardization of future research.
DATA SOURCES: PubMed, Embase (1971-2017).
STUDY SELECTION: Studies measuring extracellular mitochondrial DNA and/or N-formyl peptides in acutely ill patients.
DATA EXTRACTION: Fifty-four studies were analyzed. Data extracted included article characteristics, methods, results, and performance in clinical prediction.
DATA SYNTHESIS: The most common patient types investigated were trauma (19 studies) and sepsis (eight). In studies comparing patient mitochondrial DNA or N-formyl peptide levels to healthy controls, 38 (90.5%) reported significantly elevated mitochondrial DNA levels in patients at first reported time point, as did the one study making this comparison for N-formyl peptides. Nine studies (81.8%) reported significantly elevated plasma/serum mitochondrial DNA levels in at least one time point in patients who developed inflammatory complications of their primary pathology compared with patients without inflammatory complications. For the ability of mitochondrial DNA to predict complications or outcomes, the area under the curve was 0.7 or greater in 84.6% of receiver operating characteristic curves, and 92.9% of odds, adjusted odds, risk, and hazard ratios were statistically significant.
CONCLUSIONS: Extracellular mitochondrial DNA levels are elevated early in patients' hospital courses in many acute illnesses and are higher in patients who develop inflammatory complications. Elevated mitochondrial DNA levels may be clinically useful in risk prediction and clinical decision support systems. Further research is needed to determine the role of extracellular N-formyl peptides in systemic inflammation and their possible clinical utility.
参考来源
- Lubkin DT, Bishawi M, Barbas AS, et al. Extracellular Mitochondrial DNA and N-Formyl Peptides in Trauma and Critical Illness: A Systematic Review. Crit Care Med. 2018. PMID: 30113320. doi:10.1097/CCM.0000000000003381
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。